Income Taxes	6 Months Ended
Income Taxes	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company recorded a $(0.1) million and $0.1 million (provision for) benefit from income taxes for the six months ended June 30, 2020 and 2019, respectively. The expense for the six months ended June 30, 2020 was primarily due to the accretion of deferred tax liability associated with indefinite lived intangibles, taxes on international operations and state income taxes netted against the benefit from the release of the FIN48 liabilities due to the expiration of the statute of limitations. The benefit recorded for the six months ended June 30, 2019 was primarily due to the accretion of the deferred tax liability associated with indefinite lived intangibles, the tax effect of unrealized gains on investments recorded within other comprehensive income, taxes on international operations and state income taxes. As of June 30, 2020, the Company has provided a valuation allowance against certain federal and state deferred tax assets. Management continues to evaluate the realizability of deferred tax assets and the related valuation allowance. If management’s assessment of the deferred tax assets or the corresponding valuation allowance were to change, the Company would record the related adjustment to income during the period in which management makes the determination. As of June 30, 2020, the statute of limitations lapsed on the FIN48 liabilities, resulting in a $0.2 million benefit to the tax provision. On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (CARES Act) was enacted and signed into law. The CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. The Company is currently evaluating the impact of the CARES Act, but at present does not expect that NOL provisions of the CARES Act will result in a material benefit to the Company, since the Company has been generating taxable losses. In addition, the CARES Act allows for the deferral of payment on the Company's share of the 6.2% Social Security tax on wages paid from the date of enactment through the end of the year 2020. Half of the deferred payment amount is due by December 31, 2021, with the remainder due by December 31, 2022. While we continue to assess the impact of the CARES Act, the company opted to defer payment of these amounts starting in the three months ended June 30, 2020. This resulted in a deferral of $0.3 million in payroll taxes as of June 30, 2020.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.